Podcasts about kortney

Treatment options for eczema have come a long way, with many new non-steroidal choices. One type is the JAK inhibitor, which offers two things people have long wanted: a non-steroidal option and a more advanced option that, unlike a biologic, does not require injection. Kortney and Dr. Payel Gupta sit down with returning guest Dr. Nicole Chase, to break down what a JAK inhibitor actually is, how the pill and cream versions differ, how JAK inhibitors compare to biologics, and what to know about safety. They also cover what is new, including a topical JAK now approved for children as young as two. What we cover in this episode about JAK inhibitors for eczema What eczema really is.  How JAK inhibitors work.  Pills versus creams.  JAK inhibitors versus biologics.  Safety and side effects.  Made in partnership with The Allergy & Asthma Network. Thanks to Incyte for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

Most adults with asthma never receive education about managing their condition, even though it is proven to help with better asthma control. The reason comes down to access. In this episode, we explore a digital platform called BREATHE, built from the ground up to change that. Dr. Payel Gupta and Kortney sit down with the two lead authors behind “Development and Usability of a Digital Asthma Self-management Education Platform: BRinging Exercise, Asthma Assessments, and TeacHing to Everyone (BREATHE)” published in JACI: In Practice, March 2026. De De Gardner and Sheryl Flynn, CEO, talk about how BREATHE was developed, what the app includes, and what the data showed after patients and providers put it to the test. What we cover in this episode about asthma self-management Asthma self-management education and why most adults never receive it. How BREATHE was built using a user-centered design process, shaped by what adults with asthma and healthcare providers said they actually needed. What the BREATHE platform includes: asthma lessons, validated control assessments, and an Asthma Action Plan, all in one app, in English and Spanish. What the usability study found: adults rated the app in the 81st percentile, providers rated the dashboard in the 76th percentile, and 80% considered making a behavior change after just two weeks. Where the program is now and where it is going, including how to access the free Allergy and Asthma Network Virtual Asthma Coaching Program today. Allergy and Asthma Network Virtual Asthma Coaching Program and the Spanish program. This podcast is made in partnership with the Allergy & Asthma Network.

We are continuing our series of interviewing thought leaders in the field of allergy and immunology. Dr. Gupta and Kortney sit down with Dr. Carla Davis, the president of the American Academy of Allergy, Asthma and Immunology. What we cover in this episode about Dr. Davis and the AAAAI What the AAAAI is and why it matters to patients. A 7,000-member organization working behind the scenes to support allergy and immunology care across the US and around the world. Dr. Davis's path to the presidency. From her early experiences advocating as a fellow to her major pivot from Baylor to Howard University, the journey that shaped her priorities. Initiative: AAAAI Advocate. A new platform connecting patients and physicians directly to their legislators, making it easy to share your story and push for better access to allergy care. Initiative: AAAAI AI Task Force. A dedicated group bringing AI tools into allergy care, including AAAAI Ignite, a Netflix-style platform that helps members find and curate personalized allergy content. Initiative: The Collaborative Translational Mechanistic Research Seed Award. A $100,000 grant pairing laboratory scientists with clinical allergists to move new discoveries directly into patient care. More resources American Academy of Allergy, Asthma and Immunology AAAAI Advocate platform Allergy & Asthma Network health equity resources   This podcast is made in partnership with the Allergy & Asthma Network.  

What happens when your drumming videos blow up online… and suddenly you're touring the world behind your own band?Hi Rockstars, it's your host Lij Shaw.In this episode, I sat down with Nashville drummer and creator Kortney Grinwis, one half of the alt-pop duo Chapel, to talk about her journey from posting drum videos on the internet to building a full-time career on the road. Kortney shared how she developed her sound, her creative identity, and the instincts that guide her as both a drummer and artist.We talked about what it's really like coming up in music today - navigating the industry, learning to trust yourself, and creating your own opportunities even when the traditional path doesn't fit. Kortney opened up about the challenges she's faced as a woman in the business, how she shaped her role in Chapel, and how embracing creativity (instead of chasing perfection) helped her evolve her drumming technique and overall artistic voice.We also got deep into the collaborative side of making records and touring. Kortney broke down how she approaches drum parts that actually serve the song, how Chapel works together to build grooves and arrangements, and why staying playful and experimental keeps the whole process fun. From life on the road to finding confidence behind the kit, Kortney's story is a reminder that success comes from following the spark, trusting your instincts, and building the community around your music.Get access to FREE mixing mini-course: https://MixMasterBundle.comTHANKS TO OUR SPONSORS!http://UltimateMixingMasterclass.comhttps://usa.sae.edu/ https://www.izotope.com Use code ROCK10 to get 10% off!https://www.native-instruments.com Use code ROCK10 to get 10% off!https://www.spectra1964.comhttps://gracedesign.com/https://pickrmusic.com https://RecordingStudioRockstars.com/Academyhttps://www.thetoyboxstudio.com/Listen to the podcast theme song “Skadoosh!” https://solo.to/lijshawmusicListen to this guest's discography on Spotify:https://open.spotify.com/playlist/32lxAhAEcxNXR1GUXt9Xfg?si=woHh3rQaQh6UCxJPLA68HgIf you love the podcast, then please leave a review: https://RSRockstars.com/ReviewCLICK HERE FOR COMPLETE SHOW NOTES AT: https://RSRockstars.com/561

Kortney and Dr. Payel Gupta are joined by Tamara Hubbard, MA, LCPC, a licensed clinical professional counselor and food-allergy parent. Together, they dig into what food allergy anxiety actually looks like in teenagers, why some teens take more risks as they get older, and what parents can do to support their teens without making things worse. What we cover in this episode is about food allergy anxiety in teens: What makes teenagers a high-risk group for food allergy reactions. Independence is increasing at the exact same time parental oversight is decreasing, and that combination creates real safety concerns. What food allergy risk-taking actually looks like. It is not always what parents expect, and some of it is just teens figuring out how to belong. Food allergy social anxiety is its own distinct experience. The fear of looking different, being a burden, or standing out can drive behavior just as much as the fear of a reaction. Why parental anxiety matters more than most parents realize. The way parents talk about food allergies often directly affects how teens handle them. How to build confidence and ownership in your teen. What to do when a teen is either too anxious or not anxious enough. *********** Made in partnership with The Allergy & Asthma Network. Thanks to Genentech and Kaléo for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

Food allergy anxiety in kids is real, and it does not always look like fear. It can show up as tantrums, clinginess, control-seeking behaviors, or a child who refuses to eat at a restaurant. Child life specialist and therapist Kelsey Mora joins Kortney and Dr. Payel Gupta to unpack what is really going on.  What we cover in our episode about managing anxiety in kids Food allergy anxiety does not always look like anxiety. Tantrums, clinginess, and control-seeking behaviors can all be signs that a child is struggling. Language matters from the start. How parents explain food allergies to young children can build confidence or quietly reinforce fear. Separation anxiety and food allergies are connected. Dependence on parents can make it harder for kids to navigate school, parties, and social situations on their own. Practicing independence at home builds real-world skills. Exposure to allergens in a safe home environment teaches confidence and communication skills kids need everywhere else. Passing parental anxiety onto kids. Co-regulation starts with the caregiver, when parents are anxious, kids have a harder time calming down. Helpful resources Food allergy anxiety information from Allergy & Asthma Network Kelsey's practice and services: childlifetherapist.com  Kelsey's workbooks and resources: themethodworkbooks.com  *********** Made in partnership with The Allergy & Asthma Network. Thanks to Genentech and Kaléo for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

If you have asthma, there is a good chance you have learned to live around it. You sleep with your inhaler on the nightstand. You skip the walk because you know it will leave you breathless. This is called uncontrolled asthma, and it is more common than you think. But here is the thing: none of that is normal, and none of it is something you have to accept. Dr. Juanita Mora, allergist and immunologist, joins Kortney and Dr. Gupta to help patients figure out whether their asthma is actually being managed the way it should be, and what to do if it is not. What we cover in this episode about asthma symptoms and control What well-managed asthma actually looks like. Dr. Mora explains what life should feel like when your asthma is properly treated, and why so many patients have accepted a version of their life that is smaller than it needs to be. Why frequent flare-ups are a warning sign. Why underlying airway swelling is dangerous and why catching it early matters. The Rules of 2. Five questions covering daytime symptoms, nighttime waking, rescue inhaler use, inhaler refills, and steroid use that can help you figure out if your asthma needs more attention. When to ask for a referral. If you are answering yes to any of these questions and your treatment plan is not changing, it may be time to push for a referral to an allergist or pulmonologist who has more tools to help. First steps you can take with ControlYourAsthma.org. Dr. Mora walks through the campaign website, available in English and Spanish, including videos, the Rules of 2 quiz, and access to a free asthma coach. More resources ControlYourAsthma.org ControlarTuAsma.org Free Asthma Coach Program __________ Made in partnership with The Allergy & Asthma Network. Thanks to Sanofi-Regeneron for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.  

In this powerful teaching, Pastor Kortney Fitzhugh breaks down the reality of what it means to be "blessed and highly favored." Using the story of Noah from Genesis 6 and 7, she challenges our modern definition of favor, reminding us that Noah didn't campaign for the ark, he was drafted into it. This message is for the dreamers who have grown weary, the leaders who feel isolated, and the "overthinkers" who are tired of trying to map out a future only God can see. Pastor Fitzhugh highlights several key shifts in perspective for anyone feeling the "burden" of their assignment: -- The True Definition of Favor: Real favor is not about personal gain or social media influence, but about being recruited for a righteous work that benefits others. -- The "What" Before the "Why": God often provides specific instructions on what to build long before He explains why you are building it. -- Attendance vs. Assistance: Recognizing the difference between spectators who watch you work and the "qualified help" God sends to help you carry the vision. -- The Hidden Timeline: Understanding that while the "rain" may last 40 days, the "wait" for the waters to recede can last a year, and your only job is to remain obedient inside the ark. -- No Rudder, No Problem: Learning to trust God when He shuts the door and provides no steering wheel, knowing that He is the one navigating the flood. Scriptures for Further Study -- Genesis 6:8-22 -- Genesis 7:11-24 -- Psalm 34:1-3 -- Psalm 119:105 +++++++ Pastors Joseph and Robbin Davis Follow Us https://www.facebook.com/truthgatherers/ Ways to Give Cash App: $truthgatherers www.easytithe.com/TGDC Text to Give - Text the amount to (850) 898-9848

When a child is diagnosed with a food allergy, one of the first things many parents wonder is, "Did I do something wrong?" and "Did I cause my child's food allergy?" You question if it was something you ate or didn't eat during pregnancy, whether you breastfed long enough, or if you introduced foods too late. The guilt is real, and it is incredibly common. Kortney and Dr. Payel Gupta sit down with Dr. Joanne Moreau, a board-certified allergist and immunologist, to unpack exactly how food allergies develop, and why no parent should carry the weight of blame. What we cover in this episode about food allergy development and parent guilt How food allergies develop. The immune system, genetics, and environment all play a role, and science is still uncovering why. Food allergy genetics and family history. A parent with asthma, eczema, or hay fever raises a child's risk, even without a food allergy themselves. Pregnancy diet, breastfeeding, and food allergy. No conclusive evidence links what a mother eats during pregnancy, or whether she breastfeeds, to whether a child develops food allergies. Eczema and food allergy. Cracked or inflamed skin lets food proteins in before the gut can build tolerance, which can trigger sensitization. Early allergen introduction. Introducing allergenic foods between 4 and 6 months of age, and keeping them in the diet consistently, is one of the best tools we have. *********** Made in partnership with The Allergy & Asthma Network. Thanks to Genentech and Kaléo for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.  

If you treat patients with asthma, this episode is for you. Not just allergists, but GPs, pediatricians, family medicine doctors, urgent care providers, and anyone who sees a patient with asthma in their practice. Dr. Cherie Zachary, current president of the American College of Allergy, Asthma and Immunology, joins Kortney and Dr. Payel Gupta to talk about why uncontrolled asthma remains a serious and largely preventable problem, and what providers can do differently starting with their next patient visit. What we cover in this episode about uncontrolled asthma The data behind the problem. ER visits, hospitalizations, and asthma deaths have not improved in years, and Dr. Zachary explains why that should concern every provider who treats asthma patients. An ER visit is a treatment failure. Dr. Zachary makes the case that any asthma patient who ends up in urgent care or the emergency room should trigger an immediate reassessment of their treatment plan, not just a course of steroids and a send-home. Five questions every provider should be asking. The episode walks through a standardized set of control questions designed to help providers catch uncontrolled asthma before it becomes a crisis, covering steroid use, ER visits, rescue inhaler use, nighttime waking, and daily activity limitations. Why patients normalize their symptoms. Providers hear what controlled asthma should actually look like, and why patients often don't volunteer the information needed to catch a problem. Who is most at risk. Dr. Zachary shares which patient populations are most likely to have uncontrolled asthma and least likely to be identified, and what providers can do to close that gap. More resources about uncontrolled asthma ControlYourAsthma.org  Free AAN Asthma Coach Program Find an allergist Understanding Oral Corticosteroid Overuse in Asthma Made in partnership with The Allergy & Asthma Network. Thanks to Sanofi-Regeneron for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

Food allergy bullying is more common than most parents realize, and most kids never bring it up on their own. Research shows it affects up to 1 in 3 children with food allergies, and the signs can be easy to miss: a lunchbox that keeps coming home full, a sudden reluctance to go to school, or quietly backing off from safe food habits to avoid standing out. In this episode, psychologist Dr. Amanda Whitehouse joins Kortney and Dr. Payel Gupta to talk about what food allergy bullying actually looks like, how to start a conversation with your child without shutting them down, and when and how to bring the school into it. What we cover in this episode about food allergy bullying What food allergy bullying looks like. From verbal teasing and social exclusion to threats involving allergens, and how it differs from everyday teasing. Signs your child may be being bullied. Behavioral shifts to watch for include school avoidance, changes in eating habits, and withdrawal from activities they used to love. How to start the conversation. Why open-ended questions and connection before action are key to getting your child to open up. When and how to involve the school. How to approach teachers and administrators, know your child's rights, and document what's happening. Building resilience after bullying. How involving your child in the solution, rather than swooping in to fix it, helps them feel empowered rather than powerless. *********** Made in partnership with The Allergy & Asthma Network. Thanks to Genentech and Kaléo for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

Kortney and Dr. Payel Gupta sit down with Nissa Shaffi, MS, Director of Advocacy at the Allergy & Asthma Network, to talk about what patient advocacy really means, how the healthcare system works as a whole, and how everyday people with allergies, asthma, and related conditions can learn to use their voice to push for real change. What we cover in this episode is patient advocacy for allergy and asthma Anyone can be an advocate. Advocacy is not just for politicians or lawyers. It is for anyone who sees a problem and wants to do something about it, from patients, caregivers, doctors, and everyday people alike. Forms of advocacy, from social media to Capitol Hill. You do not have to fly to Washington to make a difference. Advocacy starts with education, storytelling, and showing up in whatever way you can. How the healthcare system actually works. No single insurance company, hospital, or drug maker is to blame for everything. Understanding the whole system is what makes advocacy effective. Why your story can change a law. Personal experience is one of the most powerful tools in advocacy. Real patient stories have driven landmark legislation and saved lives. PALI, the Patient Advocacy Leadership Initiative. A free monthly program from the Allergy & Asthma Network that teaches patients the language, tools, and knowledge they need to advocate confidently at any level. More resources PALI (Patient Advocacy Leadership Initiative):  Allergy & Asthma Day on Capitol Hill (AADCH) AAN Advocacy Center, take action today!  Bills Allergy & Asthma Network is prioritizing this year: Safe Step Act EPIPEN Act HELP Copays Act  One School One Nurse Act See all the bills on the Network's Advocacy page *********** Made in partnership with The Allergy & Asthma Network.

GO JETS GO / First World War statue unveiled at new location on Vimy Ridge Day (0:30); Sounds of the Game JETS STILL ALIVE (7:35); It's National Pet Day! Let's chat about times our pets caused CHAOS and MAYHEM (12:30); Trump fires back at the likes of Megyn Kelly & Alex Jones, & Melania Trump says 'lies' linking her to Jeffrey Epstein need to end now (21:10); THE COUCH POTATOES! (28:15); Weekly U.S. recap with Global's Reggie Cecchini (40:15); Chat on Gladu and floor crossing / Poilievre downplays questions over future after 4th Conservative MP's defection (46:45); CLAYHEM!!! (56:10); Winning entry on pets causing chaos (1:03:55); New Home Network show: Life is Messy, with Kortney & Kenny (1:08:35).

If you have ever taken an antihistamine labeled "non-drowsy" and still ended up foggy and tired, you are not imagining it. Allergists have a lot to say about that label and about the foggy feeling that comes with allergy season in general. In part two of our live recordings from the AAAAI conference in Philadelphia, Kortney and Dr. Payel Gupta talk to allergists from across the US about what they actually think about antihistamines. What we cover in this episode about antihistamines: Non-drowsy does not mean the same thing for every antihistamine. Zyrtec, Claritin, and Allegra are all labeled non-drowsy, but some are more likely to make you sleepy than others. Why allergists have moved away from Benadryl. First-generation antihistamines cross into the brain more easily, causing drowsiness and a range of other side effects that are far less common with newer antihistamines. The foggy feeling might not be your medication. Congestion from untreated allergies disrupts your sleep, and poor sleep creates its own fog. Sometimes it is the disease, not the drug. Timing your antihistamine makes a real difference. Taking it before you head out gives it the best chance to work. And if it makes you drowsy, switching to a nighttime dose is a simple fix. Not all second-generation antihistamines are approved for pilots. Fexofenadine has the lowest penetration into the brain of any antihistamine tested, which is why the FAA cleared it as the only option pilots can take while flying. Second-generation antihistamines (non-sedating or minimally sedating) Cetirizine — Zyrtec Loratadine — Claritin, Alavert Fexofenadine — Allegra Levocetirizine — Xyzal Desloratadine — Clarinex (prescription only) First-generation antihistamines (sedating) Diphenhydramine — Benadryl, ZzzQuil, Unisom Chlorpheniramine — Chlor-Trimeton Brompheniramine — Dimetapp Dimenhydrinate — Dramamine Hydroxyzine — Atarax, Vistaril (prescription only) Thank you to our allergists A huge thank you to every allergist who stopped what they were doing at the AAAAI conference to talk to us. We could not make this episode without you. Dr. Mansi Kotwal, Instagram Dr. Lauren Davidson, Instagram Dr. Joel Brooks, LinkedIn Dr. Pratibha Vakharia, allergyv.com Dr. Rathika Gupta Dr. David Wertheim Thanks to Opella for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.  

Send us Fan MailIf you feel like you're doing everything right but still feel exhausted, flat, or just off, this episode is for you.In this episode, Kortney breaks down what burnout actually looks like (beyond just being “too busy”), especially for women in their 40s and 50s navigating changing energy, hormones, and life demands.You'll learn why burnout isn't just about doing too much, the hidden patterns that keep you stuck, and how to start supporting yourself differently (without adding more to your plate).✨ In this episode: Why burnout is about constant pressure, not just a full schedule  The patterns driving burnout (perfectionism, over-functioning, invisible load)  How burnout shows up in your body, mind, and energy Why this season of life can make everything feel harder  Simple shifts to start breaking the cycle ❤️ Ready for more support?If this resonated, this is exactly the work I do with my clients - helping you reconnect with your energy, your body, and your life in a way that actually feels good.

Ep. 150: What Allergists Really Think About Your Allergy Nasal Spray If you have ever grabbed a nasal spray off the pharmacy shelf, used it for a few days, and given up because nothing seemed to be happening, you are not alone. And according to the allergists we spoke to at the AAAAI conference in Philadelphia, that is not uncommon. In this episode, Kortney and Dr. Payel Gupta share real conversations with allergists from across the US about what they actually think about allergy nasal sprays. What we cover in this episode about allergy nasal sprays Why allergists love nasal steroid sprays. They work at the source of the problem by calming swelling inside the nose before your symptoms have a chance to take hold, and you can pick them up at the grocery store without a prescription. You may not feel the nasal spray work right away. Nasal steroid sprays need about two weeks of consistent daily use before you feel a difference. The medication is working, you just cannot feel it yet. Do not give up early. When to start before allergy season. Starting your spray a couple of weeks before your season hits means you go in with as little swelling inside your nose as possible, giving the medication the best chance to work. Why so many patients stop using their spray. Incorrect technique causes irritation and nosebleeds, and means the medication is not landing where it needs to. Not all nasal sprays smell or feel the same. If the smell or taste of your spray puts you off, there are options without it, and that is worth a conversation with your allergist or pharmacist. Thank you to our allergists A huge thank you to every allergist who stopped what they were doing at the AAAAI conference to talk to us. We could not make this episode without you. Dr. Jessica Hui, Instagram | LinkedIn Dr. Jamie Rutland, Instagram | Instagram: The Health Exchange Podcast Dr. Juan Carlos Murillo, Instagram | LinkedIn Dr. Tobi Olayiwola  Dr. Jake Rosenblum, LinkedIn Dr. David Wertheim Dr. Sonali Majmudar, Instagram | LinkedIn Thanks to Opella for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.  

Chronic sinusitis without nasal polyps is the most common form of chronic sinusitis. Even so, most patients spend years without a clear explanation, cycling through antibiotics that do not address what is actually going on. In this episode, Kortney and Dr. Payel Gupta are joined by Dr. Michael Blaiss and Dr. Anju Peters, an allergist and immunologist at Northwestern University who co-authored the 2025 Adult Sinusitis Clinical Practice Guideline. Together, they break down what chronic sinusitis without nasal polyps (CRSsNP) actually is, what the real quality-of-life impact looks like, and how a proper diagnosis is confirmed. What we cover in this episode about chronic rhinosinusitis without nasal polyps Not an infection. Chronic sinusitis without nasal polyps is driven by inflammation lasting 12 weeks or more, not by bacteria or a virus, which is why antibiotics often do not help. The hidden quality of life burden. Beyond congestion and sinus pressure, patients commonly experience fatigue, poor sleep, anxiety, depression, and social isolation. Why so many patients go years without a correct diagnosis. Symptoms overlap significantly with conditions like allergic rhinitis or migraines. Many patients adapt to feeling unwell rather than seeking answers. How doctors confirm the diagnosis. A diagnosis requires objective evidence of inflammation, as seen on nasal endoscopy or a CT scan of the sinuses, not symptoms alone. The connection between sinusitis and asthma. The nose, sinuses, and lungs share one connected airway, and about 60% of people with this condition also have asthma, with each capable of making the other worse. *********** Made in partnership with The Allergy & Asthma Network. Thanks to Insmed for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

Chronic hives that come and go without warning are exhausting physically and emotionally. But here is something many patients don't realize: feeling "okay" is not the same as being well controlled. Kortney and Dr. Gupta are joined by Dr. Tom Chacko, a board-certified allergist and immunologist based in Atlanta, to discuss what good hives control actually looks like and what to do when you are not there yet. From "just living with" your condition to managing a bad flare, tracking your symptoms, and preparing for your follow-up appointment, this episode gives you the tools to stop just coping and start getting better care. What we cover in our episode about what chronic hives control looks like: Chronic spontaneous urticaria. The plain-language definition of CSU, including why hives appear without a clear trigger and what angioedema is. The trap of normalizing symptoms. Why patients adjust their lives around hives without realizing it, and how to spot the signs that your condition is not actually controlled. How to track your hives. Why symptom tracking helps with diagnosis and better care, and how to use tools like the UAS7 score. What to bring to your follow-up appointment. The concrete information your doctor needs to work with you to find the best treatment plan. This includes information about sleep, daily activity, and medication side effects. How to ask for more help. What to say when antihistamines are not enough, and what newer treatment options exist for CSU patients today. More resources about chronic hives UAS-7 Urticaria Activity Score worksheet Allergy & Asthma Network chronic urticaria resources More episodes about hives *********** Made in partnership with The Allergy & Asthma Network. Thanks to Novartis for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

In this episode of the FinTech Hunting Podcast, Michael Hammond sits down with Kortney Lane-Schafers of MMI (Mobility Market Intelligence) for a powerful conversation about where the mortgage industry is headed—and what still matters most as technology moves faster than ever.Yes, AI is changing the game.Yes, data is more available than ever.But here's the deeper question:In a market driven by automation, what still creates trust, momentum, and real growth?Kortney shares how MMI One is helping mortgage professionals turn data into action—not just reports, dashboards, or noise, but real business decisions around recruiting, retention, market expansion, customer outreach, and borrower opportunity.This episode goes beyond product talk. It gets to the heart of what many leaders are wrestling with right now:How do you use mortgage data in a way that is actually useful?What role should AI play in relationship-driven industries?How can lenders, servicers, banks, and credit unions better activate their databases?Why do authentic human relationships still outperform transactional selling?What makes an industry experience memorable instead of forgettable?Kortney also shares her perspective on why connection still matters, why the best networking is never just about selling, and how thoughtful experiences can create lasting impact across the mortgage and fintech ecosystem.If you work in mortgage, fintech, lending, servicing, banking, credit unions, proptech, sales, recruiting, or growth strategy, this conversation will give you both practical insight and a meaningful reminder:Technology may accelerate business, but relationships still move it forward.Key takeaways from IMB and why optimism is returning to mortgage in 2026What MMI One is and how it unifies mortgage data, communications, and monitoringHow lenders can use data for market growth, recruiting, retention, and referral developmentWhy actionable data matters more than just having more dataHow mortgage teams can use triggers and insights to deliver the right message at the right timeThe growing role of AI, automation, CRM integration, and credit monitoringWhy live events, networking, and authentic connection still matter in a digital-first worldHow meaningful experiences build stronger business relationships in mortgage and fintechKortney Lane-Schafers is a respected voice in mortgage and fintech, known for her work at MMI, her leadership in building authentic industry relationships, and her ability to connect data, strategy, and people in a way that creates real impact.The mortgage industry does not need more noise.It needs more clarity.More intentionality.And more leaders who understand that the future belongs to the organizations that can blend data, AI, and human connection the right way.If that's the future you're building toward, this episode is for you.Connect with Kortney Lane-Schafers on LinkedInLearn more about MMI: MMI.ioSubscribe to FinTech Hunting for more conversations with the leaders shaping mortgage, fintech, AI, marketing, growth, and the future of financial services.In this episode, we cover:About Kortney Lane-Schafers Why this conversation matters.###Michael Hammond, Founder of NexLevel Advisors, is the leading fractional CMO in mortgage and mortgage technology, specializing in AI-powered growth strategy and audience development.

If you have chronic hives and antihistamines aren't helping, there's a new treatment option to know about. In this episode of The Itch Review, we spotlight "Remibrutinib in Chronic Spontaneous Urticaria" published in The New England Journal of Medicine, March 2025. This article looks at the REMIX trials, which tested whether remibrutinib, a BTK inhibitor, can help adults whose chronic spontaneous urticaria (CSU) is not controlled by antihistamines alone. Remibrutinib works differently from antihistamines. Instead of blocking histamine after it's released, it stops mast cells from releasing those itch-causing chemicals in the first place. The FDA approved remibrutinib in September 2025.  What we cover in our episode about the REMIX trial: Understanding CSU: Chronic spontaneous urticaria causes itchy hives and swelling for more than 6 weeks with no clear trigger, and antihistamines don't work for everyone. How remibrutinib works: This BTK inhibitor stops mast cells from releasing chemicals like histamine, rather than blocking histamine after it's already released. Why do two identical trials: Running the same study twice (REMIX-1 and REMIX-2) with different patients helps prove the results are real, not a fluke. Key results: About half of patients reached well-controlled disease, and about 1 in 3 became completely clear of hives and itch. Safety and side effects: Petechiae (tiny dots of bleeding under the skin) were the main thing to watch for, but most cases were mild and went away on their own. DOWNLOAD THE INFOGRAPHIC More resources about chronic hives Chronic Spontaneous Urticaria - Allergy & Asthma Network Chronic Urticaria Toolkit What are hives? All episodes on urticaria *********** The Itch Review, hosted by Dr. Gupta, Kortney, and Dr. Blaiss, explores allergy and immunology studies, breaking down complex research in conversations accessible to clinicians, patients, and caregivers. Each episode provides key insights from journal articles and includes a one-page infographic in the show notes for easy reference. *********** Made in partnership with The Allergy & Asthma Network. Thanks to Novartis for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

Chronic rhinosinusitis with nasal polyps, or CRSwNP, is a condition driven by ongoing inflammation. That is why treatment is not a one-time fix and why polyps can come back even after surgery. In this episode, Dr. Payel Gupta and Kortney are joined by Dr. Maeve O'Connor, a board-certified allergist and immunologist, to walk through CRSwNP treatment options. This episode is released around World Anosmia Day because loss of smell is one of the most frustrating and most common symptoms of CRSwNP, and one that treatment can actually help with. What we cover in this episode about nasal polyps treatment Nasal therapies as your base management: Saline rinses and nasal steroid sprays are the foundation of CRSwNP treatment. They need to be used consistently as part of your daily routine, not just when symptoms flare. Why nasal polyps keep coming back: CRSwNP is driven by ongoing inflammation, not just the polyps themselves, so removing them does not address the root cause. When surgery is the right choice: Sinus surgery can open blocked passages and help nasal sprays reach deeper into the sinuses, but works best as part of a long-term plan, not a one-time fix. What biologic medications actually do: Biologics target the underlying inflammation causing CRSwNP. Four are currently approved for CRSwNP: dupilumab, omalizumab, mepolizumab, and tezepelumab. Why follow-up care matters even when you feel better: Inflammation can return before symptoms become noticeable, so regular check-ins with your allergist or ENT are key to catching early signs of polyp regrowth. About our guest  Dr. Maeve O'Connor, MD, FACAAI, FAAAAI, is a board-certified allergist and immunologist and founder of Allergy Asthma & Immunology Relief (AAIR) of Charlotte, North Carolina. She treats patients of all ages, practices integrative medicine, and has been named a Top Doctor by Charlotte Magazine since 2007. More resources What is Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)? What are nasal polyps? What is AERD? Biologics for Allergic Disease What to know before starting a biologic  Oral Corticosteroid Stewardship   ********* Made in partnership with The Allergy & Asthma Network. Thanks to Sanofi-Regeneron for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

What if growth in 2026 isn't about doing more — but choosing better? In this keynote from Benjamin Mena's Elite Recruiter Sales & BD Summit, Kortney Harmon reframes what winning looks like in today's staffing market.In this episode, you'll hear insights from Kortney Harmon's keynote at Ben Mena's Sales and BD Summit, where she explores why narrowing focus, redesigning revenue strategy, and protecting the right relationships are critical in today's staffing market. As sales cycles lengthen and effort becomes more expensive, Kortney breaks down how intentional account selection, system alignment, and leadership judgment can eliminate wasted activity and margin erosion. From confronting burnout and revenue concentration to building repeatable processes that reduce reliance on heroics, she shares practical frameworks to help firms move from reactive selling to relationship-driven growthWhether you're an agency leader, full-desk producer, or building the next phase of your firm's growth, this episode challenges you to rethink where your effort is going — and whether it's truly compounding.____________Follow Benjamin Mena LinkedIn: LinkedIn: BenjaminBenjamin Mena with Select Source Solutions: hereThe Elite Recruiter Podcast Instagram: https://www.instagram.com/theeliterecruiter/Follow Crelate on LinkedIn: CrelateWant to learn more about Crelate? Book a demo hereSubscribe to our newsletter: The Full Desk Experience

We spend about 90% of our time indoors. But what's actually in that air we breathe, and why does it matter so much for people with asthma, allergies, and eczema? This is part two of our series about indoor air quality. We discuss how you can improve your indoor air quality. Kortney shares her experience living in Germany, where ventilating your home isn't just a suggestion, it's practically a lifestyle. We also go room by room with practical tips you can actually use, from washing your sheets in hot water to why that scented candle might need to go. Part one covered what causes bad indoor air quality and what causes health problems for people with asthma and allergic diseases. What we cover in part two about indoor air quality The art of Lüften, aka house burping: Fully opening your windows for 5 to 10 minutes is better than cracking them all day, but skip it during peak pollen season. How to reduce dust mites in your bedroom: Hot water washes, dust mite covers, humidity control between 30 and 50 percent, and keeping stuffed animals off the bed. What to know about air purifiers: HEPA filters catch particles, carbon filters catch chemicals, and size matters for your room. Some cleaning products may make things worse: Choose fragrance-free products, avoid aerosols and scented candles, and wear a mask while cleaning. Kitchen and bathroom tips: Run exhaust fans during and after cooking or showering, check for leaks, and watch your shower curtain for mold. Advocating for better air at school and work: Ask about ventilation and MERV filters, and pay attention if your symptoms improve on weekends. More resources Allergy & Asthma Network: Healthy at Home Allergy & Asthma Network: Healthy at Work EPA Indoor Air Quality Tools for Schools EPA Safer Choice Cleaning Products EXHALE Resources Listen: Ep. 144: What is Indoor Air Quality and Allergic Disease (Part 1 of 2) This series is part of the EXHALE project, a set of six evidence-based strategies designed to help people with asthma achieve better health and improved quality of life. This series supports the last "E" in EXHALE by reducing asthma triggers in indoor environments. This podcast is made in partnership with Allergy & Asthma Network

Asthma is one of the most common long-term conditions in children. It is a leading cause of missed school and emergency room visits. Doctors use tools (validated questionnaires) to assess how well a child's asthma is controlled and whether their medicine is helping. Some tools only ask about symptoms, which can miss children who are still at risk for asthma attacks. The lead author, Dr. Kevin Murphy, joins us to talk about “Pediatric Asthma Impairment and Risk Questionnaire: A Control Assessment for Children Aged 5 to 11 Years,” published July 2025 in Journal of Allergy and Clinical Immunology: In Practice. The Peds-AIRQ was designed to improve how doctors identify uncontrolled asthma in children by asking about both current symptoms and past asthma attacks. This approach helps avoid missing children who may seem okay day to day but are at higher risk for future flare-ups. What we cover in this episode Why asthma control in children can be hard to measure What “controlled asthma” really means Why past asthma attacks matter, even when symptoms seem mild What the Peds-AIRQ is and how it works How this tool may support better conversations between families and doctors DOWNLOAD THE INFOGRAPHIC More asthma in kids resources  Take the Peds-AIRQ questionnaire  What is asthma? Asthma in Babies and Children Childhood Asthma: A Complex Condition That Doesn't Have to Be So Complicated - video *********** The Itch Review, hosted by Dr. Gupta, Kortney, and Dr. Blaiss, explores allergy and immunology studies, breaking down complex research in conversations accessible to clinicians, patients, and caregivers. Each episode provides key insights from journal articles and includes a one-page infographic in the show notes for easy reference. *********** Made in partnership with The Allergy & Asthma Network. Thanks to AstraZeneca for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

Is the recruiting industry actually changing—or simply recalibrating? Kortney Harmon cuts through the noise to examine what's really shaping recruiting leadership as firms look toward 2026. Rather than chasing headlines or hyped predictions, this Express episode outlines eight quiet but powerful signals emerging from real conversations with owners, operators, and executives. Kortney explores why relationships are becoming strategic again, how discipline is replacing tech accumulation, and why AI is shifting from competitive advantage to expected infrastructure. The conversation reframes growth around sustainability, trust, and clarity—highlighting the rise of operator-strategists, the redefinition of candidate experience, and the identity questions firms can no longer avoid.Grab a coffee and tune in for quick, practical inspiration to help you lead and grow your talent business—with less chaos and more purpose.______________________Follow Crelate on LinkedIn: CrelateWant to learn more about Crelate? Book a demo hereSubscribe to our newsletter: https://www.crelate.com/blog/full-desk-experience

What happens when candidate submissions disappear—and no one can explain why? In this FDE Express episode, host Kortney Harmon breaks down how undefined submission processes quietly drain revenue and momentum.Drawing on real-world audits, Kortney reframes failed submissions as an operational issue, not a recruiter problem. She outlines how inconsistent formats, missing follow-up, and lack of visibility create a costly “figure it out” tax—and what a revenue-protecting submission framework actually looks like.Key Takeaways• Why submissions are as revenue-critical as invoicing• The hidden cost of letting recruiters “figure it out”• What a standardized, flexible submission process includes• How visibility and tracking protect placements and momentumListen in for practical strategies you can implement immediately to bring consistency and control back to your submission process.___________________Follow Crelate on LinkedIn: CrelateWant to learn more about Crelate? Book a demo hereSubscribe to our newsletter: https://www.crelate.com/blog/full-desk-experience

Clonal mast cell disease is often missed because symptoms vary from person to person, tryptase levels can be normal, and bone marrow biopsies are hard to get. For some people, unexplained or very severe anaphylaxis may be an early sign of a clonal mast cell disease. In this episode, we review “Prevalence of KIT D816V in anaphylaxis or systemic mast cell activation,” published in October 2025 in the Journal of Allergy and Clinical Immunology. This paper, known as the PROSPECTOR trial, is looking at how often the KIT D816V mutation can be found using a blood test in adults who have had anaphylaxis or systemic mast cell activation symptoms. We break down why KIT D816V matters, how it connects to systemic mastocytosis, why HaT needs to be considered, and how newer blood tests may help doctors catch clonal mast cell disease earlier. What we cover in our episode about KIT D816V and anaphylaxis: Setting the stage: Understanding mast cell activation and anaphylaxis. Why KIT D816V matters: How this mutation fits into clonal mast cell disease, what blood testing can reveal, and when doctors still turn to a bone marrow biopsy. Making sense of tryptase and hereditary alpha-tryptasemia (HaT): Why baseline tryptase, the “20% + 2” rule, and HaT can make screening more complicated than it seems. What the PROSPECTOR trial uncovered: How often KIT D816V appeared in people with anaphylaxis, and other results on tryptase and HaT. How this helps patients: What these findings mean for anyone with unexplained or severe anaphylaxis, and how doctors combine KIT testing, tryptase, HaT, and symptoms to decide on next steps. Other podcast episodes about mast cell disease: Ep. 127: Management of indolent mastocytosis - A clinical yardstick Ep. 126: Management of mast cell activation syndrome - A clinical yardstick Ep. 121: Avapritinib vs Placebo in Indolent Systemic Mastocytosis - PIONEER Trial Ep. 118: The ISM Disconnect - Do Patients and Providers Agree on Symptom Control? Ep. 70 How do stress and low histamine diets impact mast cell disease? Ep. 63: Mast Cell Diseases & Systemic Mastocytosis: The Basic Science Ep. 65: The Symptoms and Triggers of Mast Cell Disease *********** The Itch Review, hosted by Dr. Gupta, Kortney, and Dr. Blaiss, explores allergy and immunology studies, breaking down complex research in conversations accessible to clinicians, patients, and caregivers. Each episode provides key insights from journal articles and includes a one-page infographic in the show notes for easy reference. *********** Made in partnership with The Allergy & Asthma Network. Thanks to Blueprint Medicines for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

In this episode, Kortney Harmon and Chris Hesson join Benjamin Mena on The Elite Recruiter Podcast to examine how AI agents are reshaping the recruiting workflow and challenging the traditional KPIs many teams still rely on. They explore why sourcing is shifting, why volume-based activity metrics no longer reflect real performance, and how automation is redefining the recruiter's day-to-day responsibilities.Kortney and Chris break down how AI agents now support sourcing, research, data cleanup, enrichment, and workflow execution—returning hours each week while exposing the widening disconnect between legacy activity tracking and modern recruiter impact. They also discuss how measuring calls, emails, and task volume can unintentionally penalize recruiters who leverage automation effectively, and why leaders must adopt outcome-based metrics grounded in influence, advisory work, and relationship-building. The conversation highlights how living resumes, real-time data enrichment, and agent-driven workflows inside the ATS can unlock value long buried in existing databases.Listen in to explore how automation changes the work—and how humans elevate the results.________________Follow Benjamin Mena LinkedIn: LinkedIn: BenjaminBenjamin Mena with Select Source Solutions: hereThe Elite Recruiter Podcast Instagram: https://www.instagram.com/theeliterecruiter/Follow Crelate on LinkedIn: CrelateWant to learn more about Crelate? Book a demo hereSubscribe to our newsletter: The Full Desk Experience

Persistent congestion, pressure, or a reduced sense of smell often gets mistaken for allergies or a stubborn cold when it may be something more, like chronic rhinosinusitis with nasal polyps (CRSwNP). Getting the right diagnosis is the first step toward real relief. Dr. Tonya Farmer, a board-certified ENT, joins Kortney and Dr. G to explain how chronic rhinosinusitis with nasal polyps (CRSwNP) is diagnosed. She walks us through the full evaluation: what symptoms matter, what a nasal endoscopy actually shows, when a CT scan is needed, and how type 2 inflammation fits into the picture. What we cover about diagnosing CRSwNP: Key symptoms: Persistent congestion, drainage, facial pressure, and especially loss of smell are major red flags for CRSwNP. Why duration matters: Chronic means 12 weeks or longer. If symptoms keep coming back or never truly improve, it's time to look deeper. The physical exam: ENTs use nasal endoscopy to see swelling, mucus, or polyps that aren't visible from the outside. When CT scans are needed: Imaging helps confirm sinus inflammation and shows the extent of polyp growth. Additional testing: Allergy testing, IgE levels, eosinophils, and other immune markers help identify type 2 inflammation and guide next steps. When to see a specialist: If antibiotics, steroids, or over-the-counter treatments aren't helping, ask for a referral to an allergist or ENT. Early diagnosis can prevent worsening symptoms and reduce the need for surgery. Set the foundations: Ep. 133: What is Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)? ___   Made in partnership with The Allergy & Asthma Network. Thanks to Sanofi for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

Avoidance has long been the standard for managing food allergies. But new options, such as oral immunotherapy (OIT) and biologic medications like Xolair (omalizumab), are changing the landscape. With more choices available, many patients and parents are wondering how to start the conversation with their allergist and what questions to ask. Kortney and Dr. Payel Gupta talk with Dr. Shahzad Mustafa, a board-certified allergist and immunologist, about how patients can navigate today's food allergy treatments with confidence. Together, they explore what to consider before starting OIT or Xolair, how to set realistic expectations, and why strict avoidance is still the right choice for many families. What we cover about food allergy treatment options: Food Allergy Avoidance: Why it remains an effective and valid approach for many, and how to make it work in daily life, including the nuances that make every case unique. Oral Immunotherapy (OIT): What it involves, who it's best suited for, and what families should know about time, cost, and safety. Xolair (omalizumab): How this injection therapy works to reduce reactions from accidental exposures and what it doesn't do. Setting expectations: How to talk with your allergist about your goals, quality of life, and what “success” really looks like. More episodes about food allergies Ep. 129: Omalizumab for Multiple Food Allergies – The OUtMATCH Trial Ep. 98: Food Allergy Treatment and Management More resources about food allergies Food Allergy Treatment & Management ___ Made in partnership with The Allergy & Asthma Network. Thanks to Genentech for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.  

When it comes to keeping kids with food allergies safe at school, school nurses are often the quiet heroes behind the scenes. From managing allergy action plans and emergency responses to training teachers and organizing care for hundreds of students, their role is essential, but often misunderstood. Kortney and Dr. Payel Gupta sit down with Elizabeth Elliott, a school nurse and President of the Maryland Association of School Health Nurses. Liz shares what really happens inside the health room and how school nurses coordinate care for students with food allergies and asthma. Plus, why communication between families and school staff is key to keeping kids safe. After this episode, you'll have a whole new appreciation for your school nurse and a better understanding of how to partner with them to make every school day safer for kids with allergies. What we cover about food allergy management at school: The school nurse's role: How nurses bridge communication between families, teachers, and doctors to keep children with food allergies safe and included during the school day. Coordinating care: How school nurses use action plans and 504s to ensure everyone, from teachers to cafeteria staff, knows how to keep kids safe. Training and emergency preparedness: How school nurses teach staff to recognize anaphylaxis, use epinephrine, and stay calm during an emergency. Field trips, cafeterias, and bus safety: What goes into planning safe experiences beyond the classroom, and why “no-food on the bus” rules really matter. Advocating for resources: How families can support their school nurses and advocate for better funding, staffing, and allergy awareness in schools. ___ Made in partnership with The Allergy & Asthma Network. Thanks to Genentech for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

Mucus plugging is a challenge in asthma care. It's thick, sticky mucus that blocks the airways and doesn't respond to regular inhalers. Even when inflammation improves, these plugs can lower lung function, limit how well medicine works, and make asthma harder to control. In this episode, we break down the study: “Effect of Dupilumab on Mucus Burden in Patients with Moderate-to-Severe Asthma,” published October 28, 2025. The analysis looks at whether dupilumab (Dupixent), a biologic that blocks IL-4 and IL-13, can lower mucus burden and improve lung function, especially in people who start with a high “mucus plug score.” What we cover in our episode about dupilumab and mucus plugging Why mucus plugging matters in asthma: Discover how thick, sticky mucus can block airways, make it harder to breathe, and why standard inhalers and steroids don't clear these plugs. How dupilumab may help: Learn how this biologic blocks IL-4 and IL-13, two key drivers of type 2 inflammation that increase mucus production and thickness. Inside the VESTIGE study: Hear how researchers measured mucus burden using CT scans and “mucus plug scores” to see if dupilumab could reduce plugging in moderate-to-severe asthma. What the results showed: Find out how dupilumab lowered mucus plug scores, reduced airway inflammation, and improved lung function (FEV₁), especially in people with high mucus burden. What this means for patients: Learn why identifying and treating mucus plugging may help improve breathing, reduce flare-ups, and make asthma easier to manage day to day.

Book a free 15-minute Growth Call here: https://go.thecontractorfight.com/15min-free-callWhen the government shuts down and projects freeze, how do you keep your business alive?Tom sits down with Kortney B. Farhat, a veteran in contracting and finance, to talk about how to stay in control when the economy gets messy. From cashflow survival tactics to Section 179 tax strategy and real-world lending options, this episode shows you how to fight back instead of panic.This is a straight-talking session about leadership, visibility, and making smart moves when everyone else is waiting for help.⚒️ Topics Covered:Why cashflow > profit during hard timesHow to keep your crew paid when receivables are slowCreative funding strategies beyond SBA loansFighting back with smart tax strategyStaying visible and marketing through chaos==================================================

Living with constant congestion, facial pressure, or a loss of smell can make daily life exhausting. For many people, these symptoms are more than just allergies or a lingering cold. They may be signs of chronic rhinosinusitis with nasal polyps (CRSwNP). Dr. Rohit Katial joins Kortney and Dr. G to unpack what CRSwNP really is, how it develops, and why type 2 inflammation plays such a key role. Together, they explain what's happening inside the sinuses, what symptoms to look for, and when it's time to see a specialist. What we cover about CRSwNP: What CRSwNP means: Chronic rhinosinusitis with nasal polyps is long-term inflammation of the nose and sinuses that lasts 12 weeks or more. What nasal polyps are: Soft, fluid-filled sacs (often “grape” or “pea” sized) that block airflow and lead to congestion and smell loss. Why it happens: Type 2 inflammation drives CRSwNP. Immune messengers like IL-4, IL-5, and IL-13 cause swelling and fluid buildup in the nasal lining. Who it affects: CRSwNP often overlaps with asthma, allergies, or aspirin sensitivity (AERD or Samter's Triad), making symptoms worse. When to seek help: If congestion, pressure, or loss of smell lasts more than 12 weeks, see an allergist or an ENT specialist. Early care can prevent sinus damage and improve breathing and quality of life. More episodes to support CRSwNP Ep. 101: What is Type 2 Inflammation? Ep. 102: Comorbidities of Type 2 Inflammation -  Connecting the Dots Between Multiple Allergic Conditions Ep. 109: Tezepelumab & Nasal Polyps - Inside the WAYPOINT Phase III Trial ___ Made in partnership with The Allergy & Asthma Network. Thanks to AstraZeneca for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

Navigating food allergies is tough enough, but adding family dynamics to the mix can make things even more complicated. When loved ones don't understand you or your child's allergies or dismiss the rules meant to keep them safe, it can lead to conflict, hurt feelings, and stress for everyone involved. Kortney and Dr. Payel Gupta sit down with psychologist Dr. Amanda Whitehouse to talk about how families can find common ground when emotions run high. Together, they unpack what it means to stay regulated in difficult conversations, how to set healthy boundaries with family members, and why understanding different coping styles can help prevent conflict before it starts. What we cover about communication and boundary-setting for food allergy families: Coping styles and conflict: Learn how different stress responses, such as “fight” versus “flight,” shape how partners, parents, and relatives react to food allergy challenges. Staying calm and regulated: Understand how your body reacts to stress and how recognizing those signals can help you stay grounded during tough conversations. Setting and holding boundaries: Get practical tips for explaining what feels safe, keeping communication clear, and responding calmly when others push back. Working together as a team: Whether it's with your partner, kids, or extended family, learn how to support each other and stay united when emotions rise. Bridging family differences: Explore ways to include children and siblings in allergy safety, and approach older relatives with patience and compassion when views or communication styles differ. ___ Made in partnership with The Allergy & Asthma Network. Thanks to Genentech for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

For decades, allergists have focused on blocking what happens outside the mast cell: histamine, IgE, and interleukins. But now, there's a new way to stop allergic inflammation before it even starts: by targeting what happens inside the cell with BTK Inhibitors. Dr. Payel Gupta and Kortney are joined by Dr. Matthew Giannetti to unpack what BTK actually does and why inhibiting it represents an exciting breakthrough in allergy and immunology. Together, they explore how BTK inhibitors work, why this inside-the-cell approach is different from anything before, and what it could mean for people living with chronic spontaneous urticaria (CSU). What the episode covers about BTK inhibitors: BTK explained: Bruton's tyrosine kinase is a pivotal “last step” before mast-cell degranulation. How BTK inhibitors work: Blocking BTK can stop histamine release downstream of many outside triggers. The science: Why BTK binding is irreversible for each molecule and how the body “re-makes” BTK over time. Safety in brief: A look at petechiae (small pinpoint spots), what to monitor, and how shared decision-making guides treatment choices. The future of BTK inhibitors: Exploring their potential role in other allergic conditions.    ____ Made in partnership with The Allergy & Asthma Network. Thanks to Novartis for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

Multiple food allergies are a daily stressor for millions of families. From avoiding social events to fearing accidental exposures, it can feel like living in a constant state of alert. Until recently, there were no FDA-approved treatments that targeted more than one allergen at a time. In this episode, we break down the study: “Omalizumab for the Treatment of Multiple Food Allergies,” published in 2024 in the New England Journal of Medicine. Known as the OUtMATCH trial, it's the first large-scale study to show that omalizumab (Xolair), a biologic already used for asthma and hives, may help people with multiple food allergies by raising the threshold for reactions. We explain how omalizumab works by blocking IgE, the antibody that triggers allergic reactions, and how the study measured changes in reaction thresholds (the amount of an allergen a person can ingest before reacting). We also explore the trial design, results, safety profile, and what all of this means for the day-to-day management of food allergies. What we cover in our episode about OUtMATCH trial How omalizumab works to prevent allergic reactions: Learn how blocking IgE increases the amount of allergen needed to trigger symptoms, offering protection from small, accidental exposures. Who qualified for the OUtMATCH trial and why: Find out which patients were included and how eligibility impacted outcomes. What success looked like in this study: Understand how researchers defined protection across multiple allergens. Why not everyone responded the same to omalizumab: Explore the variability in results and what it means for clinical care. What else the study found beyond food challenges: Hear about safety findings, quality of life data, and the open-label extension.

By Adam Turteltaub Imagine that it's time to move on from compliance to another role, either by choice or being voluntold.  Does what you learned in compliance help? Absolutely, according to Kortney Nordrum, Vice President and Senior Corporate Counsel at Deluxe.  Amongst other benefits, it taught her how to break down large issues into more manageable pieces, better identify and manage risks and help deals close. That isn't to say the transition has come without challenges.  She has had to learn to trust others to run compliance and also to be less risk averse. Listen in to learn more about how your compliance skills can help if your career ever takes you to another profession.

What do the Swedish concept of lagom—living with balance and “just enough”—and the philosophy of Stoicism have in common? In this episode of the Via Stoica Podcast, Benny speaks with Kortney Yasenka, licensed clinical mental health counselor, writer, and Stoic practitioner, about how these two traditions can guide us toward a more meaningful and joyful life.Together they explore:Why asking yourself “What is enough?” is central to both Stoicism and LagomHow daily reflection on Stoic quotes can inspire real practice rather than just theoryThe balance between simplicity and fulfillment in modern lifePractical ways to bring more contentment, gratitude, and joy into your everyday routineKortney shares her personal journey, blending modern counseling with ancient wisdom, and offers insights on how both Stoicism and Lagom can help us navigate a world often dominated by excess and distraction.Follow Kortney's work here:https://yasenkacounseling.com/https://kortneyyasenka.com/https://www.linkedin.com/in/kortney-yasenka-lcmhc-0b412a35https://www.instagram.com/swedish_lagom/https://www.instagram.com/kortneyyasenka/

When people get hives or swelling, they often think it's caused by an allergy. But in the case of chronic spontaneous urticaria (CSU), the culprit is often your own immune system. CSU isn't your typical allergic reaction, instead, it's frequently an autoimmune condition, where the immune system misfires and activates mast cells without any external trigger. In this episode, Dr. Payel Gupta and Kortney unpack what it means for CSU to be autoimmune and autoallergic. They explain how IgE and IgG antibodies can trigger histamine release, leading to hives and swelling. You'll also learn why allergy testing isn't useful for diagnosing CSU, and how tests like IgG food sensitivity panels can do more harm than good by leading to unnecessary food avoidance and confusion. What we cover in our episode about autoimmune CSU and chronic hives: Is CSU an allergy? Why CSU is often mistaken for an allergic reaction—and why standard allergy tests rarely provide helpful answers. How the immune system works in CSU: What mast cells are, how they release histamine, and their central role in chronic spontaneous urticaria. Understanding autoimmune CSU: Learn how the immune system can trigger hives from within, including the roles of IgE and IgG antibodies. Autoimmune hives explained: We explore how CSU can be autoimmune, why the immune system may attack itself, and what Type I and Type IIb autoimmune CSU really mean. ____ Made in partnership with The Allergy & Asthma Network. Thanks to Novartis for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

“What is for you is not going to miss you” on the Daily Grind ☕️, your weekly goal-driven podcast. This episode features Kelly Johnson @kellyfastruns and special guest Kortney Chase, who is the founder of Pecana Milk, a dairy-free milk alternative made from organic pecans. Since launching in 2023, Pecana has stayed rooted in sustainability, community, and wellness—committed to healthy bodies, happy farmers, and a clean Earth. Kortney, welcome to the show. S7 Episode 49: 9/16/2025Featuring Kelly Johnson with Special Guest Kortney ChaseFollow Our Podcast:Instagram: @dailygrindpod https://www.instagram.com/dailygrindpod/  X: @dailygrindpod https://x.com/dailygrindpod Facebook: https://www.facebook.com/dailygrindpodTikTok: https://www.tiktok.com/@dailygrindpodPodcast Website: https://direct.me/dailygrindpod  Follow Our Special Guests:Website: https://pecanamilk.com/Instagram: @pecanamilkFacebook: https://www.facebook.com/PecanaMilkk/

Indolent Systemic Mastocytosis (ISM) is a rare but often underrecognized clonal mast cell disorder. From random hives to gut pain and brain fog, ISM can feel like a medical mystery. We continue our review of “Management of indolent mastocytosis and mast cell activation syndrome - A clinical yardstick,” published in June 2025 in The Annals of Allergy, Asthma & Immunology. This is Part 2 of our discussion, with a focus on indolent systemic mastocytosis. We look at what causes it, how it's diagnosed, and how to manage symptoms and improve quality of life. In this episode, we break down this complex mast cell disease and how doctors use baseline serum tryptase, KIT D816V testing, and HaT screening to find answers. Plus, we explain how treatments like antihistamines, mast cell stabilizers, and avapritinib can help people live better with ISM.

Welcome back to the Rundown with Jake and Nate!! Follow Kortney! https://www.instagram.com/kortneyjphoto/All of our digital assets 30% off with the code 'RUNDOWN': https://runawayvows.myshopify.com/To submit an anonymous story for our next episode, do so here:https://shor.by/podcastsubmission • Our Course Library: https://go.runawayvows.com/course• Check out our Digital Assets: https://runawayvows.myshopify.com/• Shop our LUT Pack: https://gamut.io/product/prestige/?gamut=runawayvowsUse code RUNAWAY for 15% off• Get our Thru the Lens Course: https://www.thruthelens.io/Follow us on instagram: https://www.instagram.com/runawayvows/Follow our Education: https://www.instagram.com/runawayvowseducation/Join our Facebook Community: https://www.facebook.com/groups/runawayweddings/Follow Jake: https://www.instagram.com/jakeweislerfilms/Follow Nate: https://www.instagram.com/nateahanfilm/

Welcome back to the Rundown with Jake and Nate!! All of our digital assets 30% off with the code 'RUNDOWN': https://runawayvows.myshopify.com/To submit an anonymous story for our next episode, do so here:https://shor.by/podcastsubmission • Our Course Library: https://go.runawayvows.com/course• Check out our Digital Assets: https://runawayvows.myshopify.com/• Shop our LUT Pack: https://gamut.io/product/prestige/?gamut=runawayvowsUse code RUNAWAY for 15% off• Get our Thru the Lens Course: https://www.thruthelens.io/Follow us on instagram: https://www.instagram.com/runawayvows/Follow our Education: https://www.instagram.com/runawayvowseducation/Join our Facebook Community: https://www.facebook.com/groups/runawayweddings/Follow Jake: https://www.instagram.com/jakeweislerfilms/Follow Nate: https://www.instagram.com/nateahanfilm/

Mast cell activation syndrome (MCAS) is a confusing and often misunderstood condition. If you've ever wondered about MCAS symptoms, serum tryptase testing, or how treatments like antihistamines, sodium cromolyn, and even omalizumab fit in, this episode is here to help. We review the findings from “Management of indolent mastocytosis and mast cell activation syndrome - A clinical yardstick,” published in June 2025 in The Annals of Allergy, Asthma & Immunology. Because the paper covers both diseases, we've split it into two parts. This episode focuses on mast cell activation syndrome (MCAS). GET THE INFOGRAPHIC - summary of this episode What we cover in our episode about mast cell activation syndrome: Yardsticks explained: Why the ACAAI uses yardsticks as practical, interim guidelines before full consensus statements are available. Classifying mast cell disorders: Primary (clonal), secondary (allergy/autoimmune), and idiopathic (MCAS). MCAS diagnosis criteria: Symptoms in 2 or more organ systems, objective evidence (serum tryptase or urinary metabolites tests), and positive response to therapy. Treatment strategies: Include trigger avoidance, H1/H2 antihistamines, leukotriene blockers, mast cell stabilizers (such as cromolyn and aspirin), off-label biologics like omalizumab, and epinephrine. Neuropsychiatric symptoms: Brain fog, anxiety, and depression are common and require multidisciplinary management. The Itch Review, hosted by Dr. Gupta, Kortney, and Dr. Blaiss, explores allergy and immunology studies, breaking down complex research in conversations accessible to clinicians, patients, and caregivers. Each episode provides key insights from journal articles and includes a one-page infographic in the show notes for easy reference. Made in partnership with The Allergy & Asthma Network. Thanks to Blueprint Medicines for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

Welcome back to another episode of The Full Desk Experience! In this Industry Spotlight, host Kortney Harmon sits down with Lauren Jednat to unravel the true impact of AI sourcing agents on the recruiting world. With tales from the trenches and insights from daily conversations with recruiting leaders, Lauren and Kortney dive deep into how AI is augmenting—not replacing—the human touch in staffing. From slashing hiring costs and boosting efficiency to shifting recruiter roles from repetitive sourcing to building strategic relationships, you'll hear how the old ways of recruiting aren't keeping up and why embracing AI is now essential for staying competitive. Whether you're curious about AI's ROI or worried about falling behind, this episode is packed with actionable advice and real-world examples to help you rethink your approach for 2025 and beyond. Don't miss out on this timely discussion about the future of recruitment technology and the steps you can take right now to modernize your desk._________________Follow Lauren Jednat on LinkedIn at: LinkedIn LaurenFollow Crelate on LinkedIn: https://www.linkedin.com/company/crelate/Want to learn more about Crelate? Book a demo hereSubscribe to our newsletter: https://www.crelate.com/blog/full-desk-experience

Do adults with chronic spontaneous urticaria (CSU) have a higher risk of death over time compared to people without hives? We review the findings from “Mortality in adult patients with chronic spontaneous urticaria: A real-world cohort study,” published in April 2025, in The Journal of Allergy and Clinical Immunology. While CSU is often considered a non-life-threatening condition, this large study found something surprising: people with CSU had a significantly higher risk of death, especially from suicide. Dr. G and Dr. Blaiss walk through key takeaways from a dataset of over 272,000 CSU patients and nearly 13 million matched controls. They explore what the results mean for mortality risk, clinical care, mental health screening, and the importance of proper, guideline-based treatment. What we cover in our episode about CSU and mortality risk: What is CSU? Chronic hives are an unpredictable, itchy, and sometimes painful condition. It lasts for 6 weeks or longer and can continue for years. Mental health connection: CSU affects more than skin. Anxiety, depression, and suicidal thoughts are common and serious concerns. Study findings: CSU was associated with higher mortality at 3 months, 1 year, and 5 years. Suicide risk was over 3 times higher than in people without CSU. Demographics: Younger and White patients with CSU had the highest increase in risk. Treatment impact: Patients using guideline-recommended treatments like second-generation antihistamines or omalizumab had lower death rates. INFOGRAPHIC The Itch Review, hosted by Dr. Gupta, Kortney, and Dr. Blaiss, explores allergy and immunology studies, breaking down complex research in conversations accessible to clinicians, patients, and caregivers. Each episode provides key insights from journal articles and includes a one-page infographic in the show notes for easy reference.   Made in partnership with The Allergy & Asthma Network. Thanks to Novartis for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

What happens when you target the root cause of indolent systemic mastocytosis? In this episode of The Itch Review, we unpack key findings from the article “Avapritinib versus Placebo in Indolent Systemic Mastocytosis,” published on May 23, 2023, in NEJM Evidence. Indolent Systemic Mastocytosis (ISM) is a rare chronic disease with life-altering symptoms. Until recently, treatment options were limited. We break down new data from Part 2 of the PIONEER study, which evaluated Avapritinib, a targeted therapy designed to inhibit the KIT D816V mutation that drives ISM. Dr. Gupta and Dr. Blaiss explain how Avapritinib works, how the study was designed, and what outcomes were measured, including the Total Symptom Score (TSS). Most importantly, we explore what this treatment could mean for patients with moderate to severe ISM. INFOGRAPHIC What we cover in our episode about avapritinib versus placebo: Understanding ISM: How the KIT D816V mutation causes overproduction and overactivation of mast cells. Why current treatment falls short: The limitations of best supportive care and why many patients remain symptomatic despite multiple medications. How Avapritinib works: A tyrosine kinase inhibitor that targets the KIT mutation directly, aiming to reduce mast cell activation at its source. Inside the PIONEER trial: Study design, eligibility criteria, and how outcomes like Total Symptom Score (TSS) and serum tryptase were measured. What the data showed: Improvements in symptoms, lab markers, and quality of life and what this could mean for long-term ISM care. The Itch Review, hosted by Dr. Gupta, Kortney, and Dr. Blaiss, explores allergy and immunology studies, breaking down complex research in conversations accessible to clinicians, patients, and caregivers. Each episode provides key insights from journal articles and includes a one-page infographic in the show notes for easy reference.   Made in partnership with The Allergy & Asthma Network. Thanks to Blueprint Medicines for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

In this FDE Express episode, we're having a direct, no-nonsense conversation about where recruiting teams really stand in the “post-AI era.” With AI moving from buzzword to business essential, there's a growing divide between firms still debating AI and those already reaping huge efficiency gains.Kortney will break down what the post-AI era actually means for your talent business, reveal some eye-opening stats about AI adoption in recruiting, and help you spot the warning signs if your team is falling behind. I'll also walk you through a clear roadmap to help your business catch up—fast! If you're ready to stop debating and start implementing, this episode is the wake-up call you can't afford to miss. Let's get started!__________________________Follow Crelate on LinkedIn: https://www.linkedin.com/company/crelate/Subscribe to our newsletter: https://www.crelate.com/blog/full-desk-experienceClick here to learn more about AI-Powered Strategic Recruiting with Crelate's Living Platform™